We use these tools to facilitate a comprehensive treatment plan
One participant stated: "While on Mounjaro, I couldn't smoke, but after stopping it for about a month, I went back to smoking." (Male, 8 months on GLP-1 therapy) "During the period of use, the need for nicotine noticeably decreased, but after the treatment period ended, the desire to smoke gradually increased." (Male, 6 months on GLP-1 therapy) In contrast, a subset of participants reported no observable perceived impact of GLP-1 on their smoking behavior
As Hims CFO Yemi Okupe stated during the February 24 earnings call: [W]e see our steady state weight loss offering being primarily composed of our evolving oral based solutions as well as liraglutide later this year
The FDA has approved semaglutide for weight management in non-diabetic adults with obesity through the brand name Wegovy
Use a peptide cost calculator to compare options objectively
Subgroup analyses showed that L-carnitine supplementation had a lowering effect on CRP and TNF- in trial duration 12 weeks in type 2 diabetes and BMI 25 kg/m 2